The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...
Rhode Island ranked second for its lung cancer survival rate, with more than 35% living five years post diagnosis. The state ...
By: Nicola MawsonAnyone who has seen a loved one battle lung cancer will tell you just how debilitating it is, watching them ...
Dr. Bryant Lin, a Stanford University School of Medicine physician and professor, has never smoked, but in early May 2024, he ...
Floridians are at high risk for lung cancer, and many are waiting too long to get screened, which affects their survival rate ...
Dr. Heba Ismail at Sutter Health’s California Pacific Medical Center has dedicated her career to the early detection and ...
The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer ...
Discover the heightened thromboembolic risk for metastatic lung cancer patients on immune checkpoint inhibitors. Learn about ...
According to the American Lung Association, biomarker testing gaps and low screening rates continue to hinder lung cancer ...
The new report from the American Lung Association ranks Arizona at the top for incidence rates but at the bottom for lack of ...